Why we need continuous pharmaceutical manufacturing and how to make it happen: a summary of thoughts from the international symposium on continuous manufacturing

Clive Badman; Charles L. Cooney; Robert T. Haslam; Alastair Florence; Konstantin Konstantinov; Markus Krumme; Salvatore Mascia; Moheb Nasr; Bernhardt L. Trout; Raymond F. Baddour

doi:10.1016/j.xphs.2019.07.016

Why we need continuous pharmaceutical manufacturing and how to make it happen: a summary of thoughts from the international symposium on continuous manufacturing

Clive Badman, Charles L. Cooney, Robert T. Haslam, Alastair Florence, Konstantin Konstantinov, Markus Krumme, Salvatore Mascia, Moheb Nasr, Bernhardt L. Trout, Raymond F. Baddour

Research output: Contribution to journal › Article › peer-review

120 Citations (Scopus)

38 Downloads (Pure)

Abstract

We make the case for why continuous pharmaceutical manufacturing is essential, what the barriers are, and how to overcome them. To overcome them, government action is needed in terms of tax incentives or regulatory incentives that affect time.

Original language	English
Pages (from-to)	3521-3523
Number of pages	3
Journal	Journal of Pharmaceutical Sciences
Volume	108
Issue number	11
Early online date	2 Aug 2019
DOIs	https://doi.org/10.1016/j.xphs.2019.07.016
Publication status	Published - 30 Nov 2019

Keywords

continuous manufacturing
pharmaceutical manufacturing
pharmaceutical technology

Access to Document

10.1016/j.xphs.2019.07.016

Badman-etal-JPS-2019-Why-we-need-continuous-pharmaceutical-manufacturing-and-how-to-makeAccepted author manuscript, 358 KBLicence: CC BY-NC-ND 4.0

Cite this

Badman, C., Cooney, C. L., Haslam, R. T., Florence, A., Konstantinov, K., Krumme, M., Mascia, S., Nasr, M., Trout, B. L., & Baddour, R. F. (2019). Why we need continuous pharmaceutical manufacturing and how to make it happen: a summary of thoughts from the international symposium on continuous manufacturing. Journal of Pharmaceutical Sciences, 108(11), 3521-3523. https://doi.org/10.1016/j.xphs.2019.07.016

@article{59ab93a75ed142bd8cc1be283289a00d,

title = "Why we need continuous pharmaceutical manufacturing and how to make it happen: a summary of thoughts from the international symposium on continuous manufacturing",

abstract = "We make the case for why continuous pharmaceutical manufacturing is essential, what the barriers are, and how to overcome them. To overcome them, government action is needed in terms of tax incentives or regulatory incentives that affect time.",

keywords = "continuous manufacturing, pharmaceutical manufacturing, pharmaceutical technology",

author = "Clive Badman and Cooney, \{Charles L.\} and Haslam, \{Robert T.\} and Alastair Florence and Konstantin Konstantinov and Markus Krumme and Salvatore Mascia and Moheb Nasr and Trout, \{Bernhardt L.\} and Baddour, \{Raymond F.\}",

note = "08/02/2020: This article has been made open by the publisher as part of their Covid-19-related resources.",

year = "2019",

month = nov,

day = "30",

doi = "10.1016/j.xphs.2019.07.016",

language = "English",

volume = "108",

pages = "3521--3523",

journal = "Journal of Pharmaceutical Sciences",

issn = "0022-3549",

publisher = "Elsevier B.V.",

number = "11",

}

Badman, C, Cooney, CL, Haslam, RT, Florence, A, Konstantinov, K, Krumme, M, Mascia, S, Nasr, M, Trout, BL & Baddour, RF 2019, 'Why we need continuous pharmaceutical manufacturing and how to make it happen: a summary of thoughts from the international symposium on continuous manufacturing', Journal of Pharmaceutical Sciences, vol. 108, no. 11, pp. 3521-3523. https://doi.org/10.1016/j.xphs.2019.07.016

Why we need continuous pharmaceutical manufacturing and how to make it happen: a summary of thoughts from the international symposium on continuous manufacturing. / Badman, Clive; Cooney, Charles L.; Haslam, Robert T. et al.
In: Journal of Pharmaceutical Sciences, Vol. 108, No. 11, 30.11.2019, p. 3521-3523.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Why we need continuous pharmaceutical manufacturing and how to make it happen

T2 - a summary of thoughts from the international symposium on continuous manufacturing

AU - Badman, Clive

AU - Cooney, Charles L.

AU - Haslam, Robert T.

AU - Florence, Alastair

AU - Konstantinov, Konstantin

AU - Krumme, Markus

AU - Mascia, Salvatore

AU - Nasr, Moheb

AU - Trout, Bernhardt L.

AU - Baddour, Raymond F.

N1 - 08/02/2020: This article has been made open by the publisher as part of their Covid-19-related resources.

PY - 2019/11/30

Y1 - 2019/11/30

N2 - We make the case for why continuous pharmaceutical manufacturing is essential, what the barriers are, and how to overcome them. To overcome them, government action is needed in terms of tax incentives or regulatory incentives that affect time.

AB - We make the case for why continuous pharmaceutical manufacturing is essential, what the barriers are, and how to overcome them. To overcome them, government action is needed in terms of tax incentives or regulatory incentives that affect time.

KW - continuous manufacturing

KW - pharmaceutical manufacturing

KW - pharmaceutical technology

UR - https://www.sciencedirect.com/journal/journal-of-pharmaceutical-sciences

U2 - 10.1016/j.xphs.2019.07.016

DO - 10.1016/j.xphs.2019.07.016

M3 - Article

SN - 0022-3549

VL - 108

SP - 3521

EP - 3523

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

IS - 11

ER -

Why we need continuous pharmaceutical manufacturing and how to make it happen: a summary of thoughts from the international symposium on continuous manufacturing

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this